Intercept to Announce Second Quarter 2020 Financial Results on August 10, 2020

Rhea-AI Summary

Intercept Pharmaceuticals will release its Q2 2020 financial results before markets open on August 10, 2020. A conference call will follow at 8:30 a.m. ET, offering insights from management regarding the second quarter.

The call will be accessible via the company’s investor page or by phone. Intercept focuses on novel therapeutics for progressive non-viral liver diseases, specifically primary biliary cholangitis and nonalcoholic steatohepatitis.

Positive

• Scheduled announcement of Q2 2020 financial results indicates transparency.
• Follow-up conference call demonstrates commitment to shareholder communication.

Negative

• None.

NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its second quarter 2020 financial results prior to market open on Monday, August 10, 2020. The announcement will be followed by a conference call and audio webcast hosted by Intercept management at 8:30 a.m. ET to discuss the results.

The conference call will be available on the investor page of our website at http://ir.interceptpharma.com or by calling (855) 232-3919 (toll-free domestic) or (315) 625-6894 (international) passcode 5073644. Archived webcasts will be available on Intercept’s website for approximately two weeks.

About Intercept
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Founded in 2002 in New York, Intercept has operations in the United States, Europe and Canada. For more information, please visit www.interceptpharma.com or connect with the company on Twitter and LinkedIn.

CONTACT

For more information about Intercept, please contact:

Investor inquiries: investors@interceptpharma.com

Media inquiries: media@interceptpharma.com

Source: Intercept Pharmaceuticals, Inc.

FAQ

When will Intercept Pharmaceuticals announce its Q2 2020 financial results?

Intercept Pharmaceuticals will announce its Q2 2020 financial results on August 10, 2020.

What time is the conference call for Intercept Pharmaceuticals Q2 results?

The conference call will take place at 8:30 a.m. ET on August 10, 2020.

How can I access Intercept Pharmaceuticals' Q2 2020 financial results conference call?

The conference call can be accessed through Intercept's investor page or by calling the provided numbers.

What diseases does Intercept Pharmaceuticals focus on?

Intercept Pharmaceuticals specializes in therapeutics for progressive non-viral liver diseases, including primary biliary cholangitis and nonalcoholic steatohepatitis.